Researchers discover
atomic structure of suspect Alzheimer proteins
Send a link to a friend
[July 06, 2017] By
Kate Kelland
LONDON (Reuters) - Scientists have for the
first time revealed the atomic structure of the tau protein filaments
that tangle in the brains of Alzheimer's patients and say it should
point the way towards developing new treatments for the disease.
|
Using a technique known as cryo-electron microscopy, a team from
Britain's Medical Research Council Laboratory of Molecular Biology
mapped in fine detail the tau filaments extracted from the brain of
a patient who had died with Alzheimer's.
The most common neurodegenerative disease, Alzheimer's is
characterized by two types of abnormal protein which form lesions or
clumps in the brain. Tau forms filaments inside nerve cells and
amyloid-beta forms filaments outside.
In healthy brains tau protein normally helps brain cells to function
but in the brains of people with Alzheimer's disease tau clumps up
in tangles inside the cells.
"Knowing which parts of tau are important for filament formation is
relevant for the development of drugs," said Sjors Scheres, who
co-led the research.
Since many pharmaceutical companies are using different parts of tau
to test the effect of potential drugs on filament formation, this
new knowledge "should significantly increase the accuracy of such
tests," he said.
Specialists not directly involved in the study, which was published
in the journal Nature, said its findings would prove extremely
important in future.
[to top of second column] |
"This study could take us into a new era of drug design," said James
Pickett, head of research at the Alzheimer's Society medical charity
- although he noted it can take 10 to 15 years to develop new
medicines from this early stage of discovery.
John Hardy, a professor of neuroscience at University College London
said the work was a "tour de force" which "will help us understand
the pathogenesis of Alzheimer's".
(Editing by Greg Mahlich)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|